Filing Details
NANOVIRICIDES, INC. (AMEX:NNVC) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event.
Filing Details NANOVIRICIDES, INC. (AMEX:NNVC) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event. Market Context…

NANOVIRICIDES, INC. (AMEX:NNVC) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event.
NANOVIRICIDES, INC.'s stock currently trades at $1.75 with a market capitalization of $23.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for NANOVIRICIDES, INC.'s stock.
All SEC filings for NANOVIRICIDES, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NNVC Stock Page
Browse all filings on our NNVC SEC filings page.
Public companies like NANOVIRICIDES, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Current market data
AMEX · NNVC
$1.37
Down: -$0.01 · -0.73%
Live quote updated
Keep reading